In addition, preclinical and clinical studies show that loss of PTEN resulted in inhibition of T-cell infiltration into tumors and T cell-induced tumor killing, eventually promoting resistance to T cell-mediated immunotherapy in melanoma (Peng et al., 2016a). This evidence concerns the gene PTEN and neoplasm.